Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study - Concepedia

Concepedia

Publication | Open Access

Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study

DOI Full Paper Access

315

Citations

22

References

2021

Year

Martin Hutchings, Rogier Mous, Michael Roost Clausen, Peter Johnson, Kim Linton, Martine E.D. Chamuleau, David Lewis, Anna Sureda, David Cunningham, Roberto S Oliveri,

Subcutaneous EpcoritamabLymphoid NeoplasiaDose EscalationMedicineDermatologyOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1